Diabetes specialists keep ACCORD data in perspective

Am J Health Syst Pharm. 2008 Mar 15;65(6):488, 490. doi: 10.2146/news080021.
No abstract available

Publication types

  • News

MeSH terms

  • Blood Glucose / drug effects
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / prevention & control
  • Diabetic Angiopathies / chemically induced
  • Diabetic Angiopathies / mortality
  • Diabetic Angiopathies / prevention & control*
  • Glycated Hemoglobin / analysis
  • Glycated Hemoglobin / drug effects
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Metformin / therapeutic use
  • National Heart, Lung, and Blood Institute (U.S.)
  • Practice Guidelines as Topic
  • Prediabetic State / drug therapy
  • United States

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • Metformin